Colorectal cancer is one of the most treatable cancers, especially when detected early. For those in advanced stages, ...

Be Well Hospitals has once again demonstrated its expertise in advanced surgical oncology by successfully performing a highly ...

Be Well Hospitals successfully performed a complex Cytoreductive Surgery with HIPEC for Ms. Pramila Dhayalu, tackling advanced Mucinous Adenocarcinoma. The intricate procedure was executed by a ...

“We saw a substantial drop in the number of patients undergoing primary cytoreductive surgery for ovarian cancer from about 70% of patients in 2010 to only about 37% in 2021.” The new ...

Deferred cytoreductive nephrectomy is associated with better survival compared with upfront surgery, including among fit patients receiving immunotherapy. Deferred cytoreductive nephrectomy (CN ...

Opens in a new tab or window To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian ...

Cytoreductive surgery aims to remove as much cancer as possible, while HIPEC circulates the abdomen and smaller tumor cells.

A first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of disease ...

A panelist discusses how they prioritize specific clinical and laboratory parameters when assessing response to first-line ...

This life-extending surgery combines cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and is given to patients whose bowel cancer has spread to the peritoneum, the lining of the ...

Successful treatment of mucinous adenocarcinoma with HIPEC at Be Well Hospitals by expert surgeons led by Dr. Sabarisan.